Hennion & Walsh Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-18,196
| Closed | -$565K | – | 779 |
|
|
2022
Q2 | $565K | Sell |
18,196
-462
| -2% | -$14.3K | 0.04% | 460 |
|
|
2022
Q1 | $766K | Sell |
18,658
-15,376
| -45% | -$631K | 0.04% | 406 |
|
|
2021
Q4 | $1.48M | Sell |
34,034
-18,475
| -35% | -$803K | 0.07% | 282 |
|
|
2021
Q3 | $2.63M | Sell |
52,509
-510
| -1% | -$25.5K | 0.14% | 209 |
|
|
2021
Q2 | $3.34M | Sell |
53,019
-13,275
| -20% | -$836K | 0.18% | 159 |
|
|
2021
Q1 | $6.16M | Buy |
+66,294
| New | +$6.16M | 0.37% | 66 |
|